Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide.
about
Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivoA nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivoMechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.Cancer screening by systemic administration of a gene delivery vector encoding tumor-selective secretable biomarker expressionLipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicRecent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid TumorsA tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo.A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittinEncapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastomaPhase I study of a systemically delivered p53 nanoparticle in advanced solid tumors.Targeting tumors using nanoparticle platforms: a phase I study of a systemically administered gene therapy system.Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases.Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization.Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriersThe clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.Biomaterials in siRNA Delivery: A Comprehensive Review.Chemically modified short interfering hybrids (siHYBRIDS): nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2.Targeting of phage particles towards endothelial cells by antibodies selected through a multi-parameter selection strategy.Synthesis and application of integrin targeting lipopeptides in targeted gene delivery.Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation.Targeted delivery using immunoliposomes with a lipid-modified antibody-binding protein.Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor
P2860
Q28728340-13E1DF77-03FB-472C-AFEA-7902B06E2014Q30412393-C610EAE8-217A-4BA1-8ECD-D38FC65F691BQ30485025-D0AFA98A-E0B3-41CF-BB28-FA0602F886ACQ33581506-4B2DE460-9497-470E-8F83-B68F7EE0B4B5Q33885654-A7537AE9-F3B8-44AE-8835-47EA14B832B1Q33903856-6C8DEC10-4E26-4635-B4CA-0C434AB912BEQ33911056-2B2EE83F-774B-458E-8D1B-E32209A51456Q34165321-02D940F0-9804-489F-9E66-A3EDD8FD01ABQ35088396-F51C2304-DE18-456C-861C-3526F0496055Q35662871-D9D91827-BEB7-4E42-AD3E-64324E175C6FQ35967737-4C5E98B3-59E3-4F96-94DD-A0ACE5DC0FACQ36145632-30DBB41C-BEDB-4836-BC8C-8F4BC2B5C565Q36883859-9855D198-121F-4842-A3E0-BE402F67F259Q36883899-C342BA1B-6769-40D1-AB2C-F46CC43CF758Q37101492-FF82EC4C-77B9-4CD8-9F9C-3A688B679A6DQ37211232-7096180E-EFAC-4A60-9132-222CD912A192Q37393524-6D6CE291-D223-414D-A1F4-ED14139F4451Q37491231-FD60CDE6-030A-41D5-94DB-CF51DFD8F758Q37562052-4AF9A685-3E30-4015-B001-5ADE10119085Q38971775-B3365C34-F695-4548-9CF4-3AEAF3B9A408Q40244901-FBC154B0-8BA9-4229-A6F7-81B15B195829Q42322516-688A4E7D-E5F5-4599-AE8F-4FDDCEC88057Q45884006-89A4C553-60C5-415A-8E44-180F27EE4811Q47935571-03A6529A-8B99-48BD-96BC-6467266EF70DQ47986500-624990CE-1B48-4A79-A552-0136D88B7388Q54382647-DC7F0A25-0654-4520-8910-1CC7E6B9F87CQ57137831-DD229C88-3FD3-4DAE-AC00-7A54E2F092FC
P2860
Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhanced transfection efficien ...... tidylated oligolysine peptide.
@en
Enhanced transfection efficien ...... tidylated oligolysine peptide.
@nl
type
label
Enhanced transfection efficien ...... tidylated oligolysine peptide.
@en
Enhanced transfection efficien ...... tidylated oligolysine peptide.
@nl
prefLabel
Enhanced transfection efficien ...... tidylated oligolysine peptide.
@en
Enhanced transfection efficien ...... tidylated oligolysine peptide.
@nl
P2093
P2860
P356
P1476
Enhanced transfection efficien ...... tidylated oligolysine peptide.
@en
P2093
Antonina Rait
Esther H Chang
Gözen Ertem
Kathleen F Pirollo
Laiman Xiang
Weiqun Huang
P2860
P356
10.1093/NAR/GNH049
P407
P577
2004-03-16T00:00:00Z